STW5 (Iberogast) vs placebo
Global symptoms of dyspepsia (responders) · patients with functional dyspepsia
STW5 (Iberogast) showed no clear difference in global symptoms of dyspepsia (responders) compared with placebo (low certainty).
1 finding from 1 review
- RR 1.55 [0.98, 2.47]2 studies · 324 participantsLow